Medicines Formulary

Medicines A–Z

D

Drug name	NICE TAs	Comments
Dabigatran capsules	TA249 - Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation TA327 - Dabigatran etexilate for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism	Following diagnosis of AF – use in line NICE and toolkit, initiation/recommendation by haematologist, transfer to GP with RICaD. For the treatment and secondary prevention of DVT and/or PE - use in line with NICE. Initiation/recommendation by haematologist, transfer to GP with RICaD Adults only
Dabigatran capsules		Use following hip and knee surgery – full course of treatment supplied on discharge
Dabrafenib	TA321 - Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma TA544 - Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma
Dabrafenib with trametinib	TA898 - Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer
Dacarbazine injection		For hospital use only
Daclizumab concentrate for infusion	TA441 - Daclizumab for treating relapsing–remitting multiple sclerosis	For Hospital Use Only. Please see drug safety alert. Safety alert
Dacomitinib	TA595 - Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer
Dactinomycin injection		For hospital use only
Daktacort cream	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Mild potency
Danaparoid injection		Hospital use only

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.